Switch theme
Sign up to access all valuation multiples
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.
2001
2
Last FY Revenue $0.3M
Last FY EBITDA -$0.1M
$5.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Medicofarma Biotech achieved revenue of $0.3M and an EBITDA of -$0.1M.
Medicofarma Biotech expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Medicofarma Biotech valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $0.3M | XXX | XXX | XXX |
| Gross Profit | XXX | $0.3M | XXX | XXX | XXX |
| Gross Margin | XXX | 85% | XXX | XXX | XXX |
| EBITDA | XXX | -$0.1M | XXX | XXX | XXX |
| EBITDA Margin | XXX | -43% | XXX | XXX | XXX |
| EBIT | XXX | -$0.6M | XXX | XXX | XXX |
| EBIT Margin | XXX | -169% | XXX | XXX | XXX |
| Net Profit | XXX | -$0.6M | XXX | XXX | XXX |
| Net Margin | XXX | -188% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Medicofarma Biotech's stock price is PLN 0 (or $0).
Medicofarma Biotech has current market cap of PLN 19.0M (or $5.0M), and EV of PLN 19.0M (or $5.0M).
See Medicofarma Biotech trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.0M | $5.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Medicofarma Biotech has market cap of $5.0M and EV of $5.0M.
Medicofarma Biotech's trades at 15.5x EV/Revenue multiple, and -35.7x EV/EBITDA.
Equity research analysts estimate Medicofarma Biotech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medicofarma Biotech's P/E ratio is not available.
See valuation multiples for Medicofarma Biotech and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.0M | XXX | $5.0M | XXX | XXX | XXX |
| EV (current) | $5.0M | XXX | $5.0M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 15.5x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -35.7x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -9.2x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -8.3x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -18.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMedicofarma Biotech's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.4M for the same period.
Medicofarma Biotech's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medicofarma Biotech's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Medicofarma Biotech and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -43% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 255% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medicofarma Biotech acquired XXX companies to date.
Last acquisition by Medicofarma Biotech was XXXXXXXX, XXXXX XXXXX XXXXXX . Medicofarma Biotech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Medicofarma Biotech founded? | Medicofarma Biotech was founded in 2001. |
| Where is Medicofarma Biotech headquartered? | Medicofarma Biotech is headquartered in Poland. |
| How many employees does Medicofarma Biotech have? | As of today, Medicofarma Biotech has 2 employees. |
| Is Medicofarma Biotech publicy listed? | Yes, Medicofarma Biotech is a public company listed on WAR. |
| What is the stock symbol of Medicofarma Biotech? | Medicofarma Biotech trades under MDB ticker. |
| When did Medicofarma Biotech go public? | Medicofarma Biotech went public in 2008. |
| Who are competitors of Medicofarma Biotech? | Similar companies to Medicofarma Biotech include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Medicofarma Biotech? | Medicofarma Biotech's current market cap is $5.0M |
| Is Medicofarma Biotech profitable? | Yes, Medicofarma Biotech is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
